Access the experts when you need them.
For Advisor Use Only
Why companies are exceeding expectations
Why long-term investors should pay attention
Why China could be the next biotechnology power.
Investing in toll roads, office space and healthcare
Escalating drug costs have impacted the sector.
Interest rate risk is no longer a concern.
Earnings growth could continue despite a slowing economy
Underlying data should keep the central bank on the sidelines for most of this year.
Looking beyond geopolitical headlines to evaluate companies.
Where to look for value as stocks rebound.